Key facts
- This page summarizes Sandip Kapadia's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Apr 2025, 16:10.
Sandip Kapadia - 29 Mar 2025 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- HRMY
- Reported as of
- 29 Mar 2025
- Net transaction value
- -$265,985
- SEC form
- 4
- Accepted by SEC
- 01 Apr 2025, 16:10:05 UTC
- Prior SEC filing
- 28 Jan 2025
- Next SEC filing
- 03 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christian Ulrich, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sandip Kapadia filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 01 Apr 2025.
Change
- Previous filing in this sequence was filed on 28 Jan 2025.
- Current net transaction value: -$265,985.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HRMY
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +15,000
- Change %
- Price
- $0.000000
- Shares after
- 15,000
- Date
- 29 Mar 2025
- Ownership
- Direct
HRMY
transaction
Common Stock
Tax liability
- Transaction value
- $265,985
- Shares
- -8,014
- Change %
- -53%
- Price
- $33.19
- Shares after
- 6,986
- Date
- 29 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HRMY
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -15,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 15,000
- Date
- 29 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
Footnote F2
This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.